The next wave of transcatheter heart valves is here
Edwards Lifesciences’ EVOQUE gained US Food and Drug Administration (FDA) approval in February 2024, making it the first transcatheter tricuspid…
Edwards Lifesciences’ EVOQUE gained US Food and Drug Administration (FDA) approval in February 2024, making it the first transcatheter tricuspid…